AIMS: This study examined clinical factors associated with sex differences in the use of acute reperfusion therapy (fibrinolysis or primary percutaneous coronary intervention) in ST-elevation myocardial infarction (STEMI) patients, and the interaction between sex and these factors in Sweden and Canada. METHODS: Patients with STEMI in Sweden (n=32,676 from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions) were compared with similar patients in Canada (n=3375 from the Canadian Global Registry of Acute Coronary Events) for the period 2004-2008. RESULTS: Unadjusted vs. age-adjusted odds ratios (OR) for no reperfusion (women vs. men) were for Sweden 1.57 (95% CI 1.49-1.64) vs. 1.14 (95% CI 1.08-1.20), and for Canada 1.61 (95% CI 1.39-1.87) vs. OR 1.18 (95% CI 1.01-1.39). Sex differences persisted after multivariable adjustments (including prehospital delay, atypical symptoms, diabetes), factors for which no interaction with sex was found. Among women <60 years, adjusting for atypical symptoms in Canada and angiographic data in Sweden made the greatest contribution to explaining observed sex differences. CONCLUSIONS: In both countries, acute reperfusion therapy in STEMI was used less often in women than in men. Factors associated with these sex differences appear to differ between older and younger women. Targeted interventions are needed to optimize care for women with STEMI, as well as sex- and age-stratified reporting of quality indicators to assess their effectiveness.
AIMS: This study examined clinical factors associated with sex differences in the use of acute reperfusion therapy (fibrinolysis or primary percutaneous coronary intervention) in ST-elevation myocardial infarction (STEMI) patients, and the interaction between sex and these factors in Sweden and Canada. METHODS:Patients with STEMI in Sweden (n=32,676 from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions) were compared with similar patients in Canada (n=3375 from the Canadian Global Registry of Acute Coronary Events) for the period 2004-2008. RESULTS: Unadjusted vs. age-adjusted odds ratios (OR) for no reperfusion (women vs. men) were for Sweden 1.57 (95% CI 1.49-1.64) vs. 1.14 (95% CI 1.08-1.20), and for Canada 1.61 (95% CI 1.39-1.87) vs. OR 1.18 (95% CI 1.01-1.39). Sex differences persisted after multivariable adjustments (including prehospital delay, atypical symptoms, diabetes), factors for which no interaction with sex was found. Among women <60 years, adjusting for atypical symptoms in Canada and angiographic data in Sweden made the greatest contribution to explaining observed sex differences. CONCLUSIONS: In both countries, acute reperfusion therapy in STEMI was used less often in women than in men. Factors associated with these sex differences appear to differ between older and younger women. Targeted interventions are needed to optimize care for women with STEMI, as well as sex- and age-stratified reporting of quality indicators to assess their effectiveness.
Entities:
Keywords:
Myocardial infarction; reperfusion therapy; sex differences
Authors: Ph Gabriel Steg; Stefan K James; Dan Atar; Luigi P Badano; Carina Blömstrom-Lundqvist; Michael A Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J Lenzen; Kenneth W Mahaffey; Marco Valgimigli; Arnoud van 't Hof; Petr Widimsky; Doron Zahger Journal: Eur Heart J Date: 2012-08-24 Impact factor: 29.983
Authors: Marc Cohen; Gian Franco Gensini; Frans Maritz; Enrique P Gurfinkel; Kurt Huber; Ari Timerman; Jose Santopinto; Giancarlo Corsini; Pierfranco Terrosu; Florence Joulain Journal: J Thromb Thrombolysis Date: 2005-06 Impact factor: 2.300
Authors: Harmony R Reynolds; Monvadi B Srichai; Sohah N Iqbal; James N Slater; G B John Mancini; Frederick Feit; Ivan Pena-Sing; Leon Axel; Michael J Attubato; Leonid Yatskar; Rebecca T Kalhorn; David A Wood; Iryna V Lobach; Judith S Hochman Journal: Circulation Date: 2011-09-06 Impact factor: 29.690
Authors: Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan Journal: Ann Intern Med Date: 2003-07-15 Impact factor: 25.391
Authors: Shaun G Goodman; Wei Huang; Andrew T Yan; Andrzej Budaj; Brian M Kennelly; Joel M Gore; Keith A A Fox; Robert J Goldberg; Frederick A Anderson Journal: Am Heart J Date: 2009-08 Impact factor: 4.749
Authors: Gail D'Onofrio; Basmah Safdar; Judith H Lichtman; Kelly M Strait; Rachel P Dreyer; Mary Geda; John A Spertus; Harlan M Krumholz Journal: Circulation Date: 2015-03-19 Impact factor: 29.690
Authors: Chetan P Huded; Anirudh Kumar; Nicholas Kassis; Michael J Johnson; Kathleen Kravitz; Abigail Brown; Marguerite Shanahan; Karen Trentanelli; Grant W Reed; Venu Menon; Amar Krishnaswamy; Stephen G Ellis; Damon M Kralovic; Stephen W Meldon; Samir R Kapadia; Umesh N Khot Journal: Eur Heart J Open Date: 2021-08-20
Authors: Janet Wei; Puja K Mehta; Elizabeth Grey; Ross F Garberich; Robert Hauser; C Noel Bairey Merz; Timothy D Henry Journal: Am Heart J Date: 2017-06-17 Impact factor: 4.749
Authors: Emma Larsson; Erik Zettersten; Gabriella Jäderling; Anna Ohlsson; Max Bell Journal: Scand J Trauma Resusc Emerg Med Date: 2015-12-24 Impact factor: 2.953